{"count": 6, "results": [{"_id": "35297689", "pmid": 35297689, "title": "Lung and chest wall mechanical properties in metformin-treated and untreated models of type 2 diabetes.", "journal": "J Appl Physiol (1985)", "authors": ["Schranc Á", "Fodor GH", "Südy R", "Ballók B", "Kulcsár R", "Tolnai J", "Babik B", "Peták F"], "date": "2022-05-01T00:00:00Z", "doi": "10.1152/japplphysiol.00724.2021", "meta_date_publication": "2022 May 1", "meta_volume": "132", "meta_issue": "5", "meta_pages": "1115-1124", "score": 50246.35, "text_hl": "We assessed the separate contributions of these compartments to @DISEASE_Respiratory_Tract_Diseases @DISEASE_MESH:D012140 @@@respiratory complications@@@ in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ and explored the effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @<m>DISEASE_Respiratory_System_Abnormalities</m> @DISEASE_MESH:D015619 @@@respiratory abnormalities@@@. ", "citations": {"NLM": "Schranc Á, Fodor GH, Südy R, Ballók B, Kulcsár R, Tolnai J, Babik B, Peták F. Lung and chest wall mechanical properties in metformin-treated and untreated models of type 2 diabetes. J Appl Physiol (1985). 2022 May 1;132(5):1115-1124. PMID: 35297689", "BibTeX": "@article{35297689, title={Lung and chest wall mechanical properties in metformin-treated and untreated models of type 2 diabetes.}, author={Schranc Á and Fodor GH and Südy R and Ballók B and Kulcsár R and Tolnai J and Babik B and Peták F}, journal={J Appl Physiol (1985)}, volume={132}, number={5}, pages={1115-1124}}"}}, {"_id": "35733997", "pmid": 35733997, "pmcid": "PMC9207264", "title": "Exaggerated Ventilator-Induced Lung Injury in an Animal Model of Type 2 Diabetes Mellitus: A Randomized Experimental Study", "journal": "Front Physiol", "authors": ["Schranc Á", "Fodor GH", "Südy R", "Tolnai J", "Babik B", "Peták F"], "date": "2022-06-06T00:00:00Z", "doi": "10.3389/fphys.2022.889032", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "889032", "score": 50244.414, "text_hl": "Controlled @DISEASE_Hyperglycemia @DISEASE_MESH:D006943 @@@hyperglycemia@@@ with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ may reduce the manifestations of @<m>DISEASE_Respiratory_System_Abnormalities</m> @DISEASE_MESH:D015619 @@@respiratory defects@@@ during prolonged mechanical ventilation.", "citations": {"NLM": "Schranc Á, Fodor GH, Südy R, Tolnai J, Babik B, Peták F. Exaggerated Ventilator-Induced Lung Injury in an Animal Model of Type 2 Diabetes Mellitus: A Randomized Experimental Study Front Physiol. 2022;13():889032. PMID: 35733997", "BibTeX": "@article{35733997, title={Exaggerated Ventilator-Induced Lung Injury in an Animal Model of Type 2 Diabetes Mellitus: A Randomized Experimental Study}, author={Schranc Á and Fodor GH and Südy R and Tolnai J and Babik B and Peták F}, journal={Front Physiol}, volume={13}, pages={889032}}"}}, {"_id": "40870870", "pmid": 40870870, "title": "Acne Vulgaris Associated with Metabolic Syndrome: A Three-Case Series Highlighting Pathophysiological Links and Therapeutic Challenges.", "journal": "Diagnostics (Basel)", "authors": ["Endres LM", "Bungau AF", "Tit DM", "Bungau GS", "Radu A", "Diaconu CC", "Marin RC"], "date": "2025-08-12T00:00:00Z", "doi": "10.3390/diagnostics15162018", "meta_date_publication": "2025 Aug 12", "meta_volume": "15", "meta_issue": "16", "meta_pages": "", "score": 50235.42, "text_hl": "Management strategies included topical/@<m>DISEASE_Respiratory_System_Abnormalities</m> @DISEASE_MESH:D015619 @@@systemic@@@ @DISEASE_Acne_Vulgaris @DISEASE_MESH:D000152 @@@acne@@@ therapies combined with metabolic interventions (lifestyle modifications, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (in two cases), and lipid-lowering agents). ", "citations": {"NLM": "Endres LM, Bungau AF, Tit DM, Bungau GS, Radu A, Diaconu CC, Marin RC. Acne Vulgaris Associated with Metabolic Syndrome: A Three-Case Series Highlighting Pathophysiological Links and Therapeutic Challenges. Diagnostics (Basel). 2025 Aug 12;15(16):. PMID: 40870870", "BibTeX": "@article{40870870, title={Acne Vulgaris Associated with Metabolic Syndrome: A Three-Case Series Highlighting Pathophysiological Links and Therapeutic Challenges.}, author={Endres LM and Bungau AF and Tit DM and Bungau GS and Radu A and Diaconu CC and Marin RC}, journal={Diagnostics (Basel)}, volume={15}, number={16}}"}}, {"_id": "23657947", "pmid": 23657947, "title": "The effects of sulfonylureas plus metformin on lipids, blood pressure, and adverse events in type 2 diabetes: a meta-analysis of randomized controlled trials.", "journal": "Endocrine", "authors": ["Zhang F", "Xiang H", "Fan Y", "Ganchuluun TA", "Kong W", "Ouyang Q", "Sun J", "Cao B", "Jiang H", "Nie S"], "date": "2013-12-01T00:00:00Z", "doi": "10.1007/s12020-013-9970-6", "meta_date_publication": "2013 Dec", "meta_volume": "44", "meta_issue": "3", "meta_pages": "648-58", "score": 50052.832, "text_hl": "@DISEASE_Hypoglycemia @DISEASE_MESH:D007003 @@@Hypoglycemia@@@ and nervous @<m>DISEASE_Respiratory_System_Abnormalities</m> @DISEASE_MESH:D015619 @@@system@@@ side events were more frequent among @SPECIES_9606 @@@patients@@@ treated with @CHEMICAL_Sulfonylurea_Compounds @CHEMICAL_MESH:D013453 @@@sulfonylureas@@@ plus @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ than @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ alone (RR = 6.79, 95 % CI 3.79-12.17; RR = 1.27, 95 % CI 1.03-1.57; respectively), but less in digestive symptoms (RR = 0.75, 95 % CI 0.67-0.84). ", "citations": {"NLM": "Zhang F, Xiang H, Fan Y, Ganchuluun TA, Kong W, Ouyang Q, Sun J, Cao B, Jiang H, Nie S. The effects of sulfonylureas plus metformin on lipids, blood pressure, and adverse events in type 2 diabetes: a meta-analysis of randomized controlled trials. Endocrine. 2013 Dec;44(3):648-58. PMID: 23657947", "BibTeX": "@article{23657947, title={The effects of sulfonylureas plus metformin on lipids, blood pressure, and adverse events in type 2 diabetes: a meta-analysis of randomized controlled trials.}, author={Zhang F and Xiang H and Fan Y and Ganchuluun TA and Kong W and Ouyang Q and Sun J and Cao B and Jiang H and Nie S}, journal={Endocrine}, volume={44}, number={3}, pages={648-58}}"}}, {"_id": "22841520", "pmid": 22841520, "title": "The effect of metformin on monocyte secretory function in simvastatin-treated patients with impaired fasting glucose.", "journal": "Metabolism", "authors": ["Krysiak R", "Okopien B"], "date": "2013-01-01T00:00:00Z", "doi": "10.1016/j.metabol.2012.06.009", "meta_date_publication": "2013 Jan", "meta_volume": "62", "meta_issue": "1", "meta_pages": "39-43", "score": 50047.836, "text_hl": "CONCLUSIONS: The obtained results suggest that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ may inhibit monocyte secretory function and reduce @<m>DISEASE_Respiratory_System_Abnormalities</m> @DISEASE_MESH:D015619 @@@systemic@@@ @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammation@@@ in statin-treated @SPECIES_9606 @@@patients@@@ with @DISEASE_Prediabetic_State @DISEASE_MESH:D011236 @@@prediabetes@@@. ", "citations": {"NLM": "Krysiak R, Okopien B. The effect of metformin on monocyte secretory function in simvastatin-treated patients with impaired fasting glucose. Metabolism. 2013 Jan;62(1):39-43. PMID: 22841520", "BibTeX": "@article{22841520, title={The effect of metformin on monocyte secretory function in simvastatin-treated patients with impaired fasting glucose.}, author={Krysiak R and Okopien B}, journal={Metabolism}, volume={62}, number={1}, pages={39-43}}"}}, {"_id": "22182833", "pmid": 22182833, "title": "Medical management of metabolic dysfunction in PCOS.", "journal": "Steroids", "authors": ["Duleba AJ"], "date": "2012-03-10T00:00:00Z", "doi": "10.1016/j.steroids.2011.11.014", "meta_date_publication": "2012 Mar 10", "meta_volume": "77", "meta_issue": "4", "meta_pages": "306-11", "score": 50046.523, "text_hl": "Early studies in @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@ suggested that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ indirectly reduces @GENE_INS @GENE_3630 @@@insulin@@@ level, @DISEASE_Dyslipidemias @DISEASE_MESH:D050171 @@@dyslipidemia@@@ and @<m>DISEASE_Respiratory_System_Abnormalities</m> @DISEASE_MESH:D015619 @@@systemic@@@ @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammation@@@; however, recent placebo-controlled trials failed to demonstrate significant metabolic benefit. ", "citations": {"NLM": "Duleba AJ. Medical management of metabolic dysfunction in PCOS. Steroids. 2012 Mar 10;77(4):306-11. PMID: 22182833", "BibTeX": "@article{22182833, title={Medical management of metabolic dysfunction in PCOS.}, author={Duleba AJ}, journal={Steroids}, volume={77}, number={4}, pages={306-11}}"}}]}